Cilt 3, Sayı 2, Sayfalar 106 - 110 2017-03-06

Study designs in biomarker research

Robab Ahmadian [1] , Gokhan Ocakoglu [2]

206 150

In order to advances in technology, nowadays science is facing to a large variety of biomarkers. Issues of selecting appropriate study design for biomarkers, facing with a large number of biomarkers, multiple biomarkers, and usefulness of a new biomarker the today is more complicated. Current study is an overview of the issues discussed in studies of biomarkers. 

Biomarker,study design,trial
  • [1] Institute NC. "biomarker". NCI Dictionary of Cancer Terms.
  • [2] Colburn W, DeGruttola V, DeMets D, Downing G, Hoth D, Oates J, et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Biomarkers Definitions Working Group. Clin Pharmacol Ther 2001;69:89-95.
  • [3] Jenkins M, Flynn A, Smart T, Harbron C, Sabin T, Ratnayake J, et al. A statistician's perspective on biomarkers in drug development. Pharm Stat 2011;10:494-507.
  • [4] Schilsky RL, Halabi S. Oncology Clinical Trials: Successful Design, Conduct and Analysis: Demos Medical Publishing; 2009.
  • [5] Mayeux R. Biomarkers: potential uses and limitations. NeuroRx 2004;1:182-8.
  • [6] Gosho M, Nagashima K, Sato Y. Study designs and statistical analyses for biomarker research. Sensors (Basel) 2012;12:8966-86.
  • [7] Mandrekar SJ, Sargent DJ. Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges. J Clin Oncol 2009;27:4027-34.
  • [8] Mandrekar SJ, Sargent DJ. Clinical trial designs for predictive biomarker validation: one size does not fit all. J Biopharm Stat 2009;19:530-42.
  • [9] Simon R. Biomarker based clinical trial design. Chin Clin Oncol 2014;3:39.
  • [10] Simon R, Maitournam A. Evaluating the efficiency of targeted designs for randomized clinical trials. Clin Cancer Res 2004;10:6759-63.
  • [11] Freidlin B, Simon R. Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients. Clin Cancer Res 2005;11:7872-8.
  • [12] Jiang W, Freidlin B, Simon R. Biomarker-adaptive threshold design: a procedure for evaluating treatment with possible biomarker-defined subset effect. J Natl Cancer Inst 2007;99:1036-43.
  • [13] Wang SJ, O'Neill RT, Hung H. Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset. Pharm Stat 2007;6:227-44.
  • [14] Zhou X, Liu S, Kim ES, Herbst RS, Lee JJ. Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine. Clin Trials 2008;5:181-93.
  • [15] Pencina MJ, D'Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
  • [16] Pencina MJ, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72.
Konular Sağlık Bilimleri
Dergi Bölümü Reviews
Yazarlar

Yazar: Robab Ahmadian
E-posta: robabahmadian@outlook.com
Kurum: ULUDAG UNIV
Ülke: Turkey


Yazar: Gokhan Ocakoglu
E-posta: ocakoglu@uludag.edu.tr
Kurum: ULUDAG UNIV
Ülke: Turkey


Bibtex @derleme { eurj284433, journal = {The European Research Journal}, issn = {}, address = {Sağlık Araştırmaları ve Stratejileri Derneği}, year = {2017}, volume = {3}, pages = {106 - 110}, doi = {10.18621/eurj.284433}, title = {Study designs in biomarker research}, language = {en}, key = {cite}, author = {Ahmadian, Robab and Ocakoglu, Gokhan} }
APA Ahmadian, R , Ocakoglu, G . (2017). Study designs in biomarker research. The European Research Journal, 3 (2), 106-110. DOI: 10.18621/eurj.284433
MLA Ahmadian, R , Ocakoglu, G . "Study designs in biomarker research". The European Research Journal 3 (2017): 106-110 <http://dergipark.gov.tr/eurj/issue/29661/284433>
Chicago Ahmadian, R , Ocakoglu, G . "Study designs in biomarker research". The European Research Journal 3 (2017): 106-110
RIS TY - JOUR T1 - Study designs in biomarker research AU - Robab Ahmadian , Gokhan Ocakoglu Y1 - 2017 PY - 2017 N1 - doi: 10.18621/eurj.284433 DO - 10.18621/eurj.284433 T2 - The European Research Journal JF - Journal JO - JOR SP - 106 EP - 110 VL - 3 IS - 2 SN - -2149-3189 M3 - doi: 10.18621/eurj.284433 UR - http://dx.doi.org/10.18621/eurj.284433 Y2 - 2017 ER -
EndNote %0 The European Research Journal Study designs in biomarker research %A Robab Ahmadian , Gokhan Ocakoglu %T Study designs in biomarker research %D 2017 %J The European Research Journal %P -2149-3189 %V 3 %N 2 %R doi: 10.18621/eurj.284433 %U 10.18621/eurj.284433